MIRM

Mirum Pharmaceuticals (MIRM)

About Mirum Pharmaceuticals (MIRM)

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its products pipeline includes Maralixibat, Cholbam, Ctexli, Volixibat, Brelovitug, MRM-3379, and Zilurgisertib. The company was founded by Niall O'Donnel, Michael G. Grey, and Christopher Peetz in May 2018 and is headquartered in Foster City, CA.

Details

Daily high

$97.00

Daily low

$88.88

Price at open

$90.25

52 Week High

$130.00

52 Week Low

$54.74

Market cap

6.5B

Dividend yield

0.00%

Volume

3.0M

Avg. volume

595,804

P/E ratio

-7.78

Mirum Pharmaceuticals News